Amedisys (AMED) Misses Q1 EPS by 1c; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports First Quarter 2020 Financial Results
May 6, 2020 4:15 PM EDTBATON ROUGE, La., May 06, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020.
Three-Month Periods Ended March 31, 2020 and 2019
Net service revenue increased $24.4Â million to $491.7Â million compared to $467.3Â million in 2019.Net income attributable to Amedisys, Inc. of $31.8Â million compared to $31.3Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $0.96 compared to $0.95 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $53.3Â million compared to $54.9Â million in 2019.Adjusted net service revenue of $491.7Â million compared to $467.8Â million in 2019.Adjusted net... More